Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
- 1 March 2022
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 112 (3) , 681-693
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective studyRadiotherapy and Oncology, 2012
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiation Dose–Volume Effects in Radiation-Induced Rectal InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Revised FIGO staging for carcinoma of the cervixInternational Journal of Gynecology & Obstetrics, 2009
- Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patientsThe Lancet Oncology, 2007
- Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancerRadiotherapy and Oncology, 2007
- Gastrointestinal complications of pelvic radiotherapy: are they of any importance?Gut, 2005
- Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group☆ (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTVRadiotherapy and Oncology, 2005
- Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?Acta Oncologica, 2005
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003